Search

everythinglearnresearchcommunity

for

Search:↓

The research found that COVID-19 survivors experienced long-term effects like anemia and hypertension, with age and gender being important factors, but race, income, and education had little to no impact.

The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Ninjin'yoeito, a Japanese medicine, helped stop hair loss and improved mood in two post-COVID-19 patients.

COVID-19 can cause hair and nail disorders after infection.

COVID-19 can cause significant hair loss.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The document says hair loss can happen after recovering from COVID-19 and it can cause psychological discomfort.

The DNA convention was a valuable opportunity for learning and networking, especially after COVID-19.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.

Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

COVID-19 can cause various skin issues, including rashes and lesions.

COVID-19 doesn't make alopecia areata worse.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.